SCA
IMMU

SAC Capital Advisors’s Immunomedics Inc IMMU Stock Holding History

SAC Capital Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,398,548
Closed -$6.43M – 2057
2013
Q4 		$6.43M Sell
1,398,548
-411,452
-23% -$1.83M 0.04% 451
2013
Q3 		$11.2M Buy
+1,810,000
New +$10.4M 0.06% 351

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SAC Capital Advisors's IMMU Position: Q1 2014 in Review

SAC Capital Advisors sold out of Immunomedics Inc (IMMU) in Q1 2014, closing a stake of 1,398,548 shares — an estimated $6.43M sold.

SAC Capital Advisors first reported a position in IMMU in Q3 2013 and held it in 2 quarters. The position peaked at $11.2M in Q3 2013. 75 funds tracked by Wall St. Rank hold IMMU as of Q1 2014.

  • SAC Capital Advisors reported no remaining Immunomedics Inc position as of Q1 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 1,398,548 Immunomedics Inc shares in Q1 2014, an estimated $6.43M.
  • SAC Capital Advisors first reported a position in Immunomedics Inc in Q3 2013 and held it in 2 quarters.
  • SAC Capital Advisors's Immunomedics Inc position peaked at $11.2M in Q3 2013.
  • 75 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2014.

Based on SAC Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.